Skip to content
En
Sv
Governance
Back
Governance
Governance Structure
General Meeting
General Meetings
Nomination Committee
Nomination Committees
Board of Directors
Work of the Board of Directors
Board Committees
Executive Management Team
Research and Development Leadership Team
Remuneration
Internal Control
Audit
Articles of Association
Corporate Governance Reports
Career
Back
Career
Leadership
Culture and values
Collaboration principles
Testimonials
Job openings
Open applications
Media
Back
Media
Press releases
Image bank
Subscribe
Contact us
BioArctic websites
Sweden
Norway
Finland
Denmark transparancy reporting
En
Sv
Menu
About us
Back
About us
Our Purpose
Growth Strategy
Why partner with BioArctic
Our partnerships
History
Capabilities
Culture and values
Leadership
Testimonials
Therapeutic Areas
Back
Therapeutic Areas
Our Technology
Alzheimer’s disease
Parkinson’s disease
ALS – Amyotrophic lateral sclerosis
Other indications
BrainTransporter™ Technology
Pipeline
Sustainability
Back
Sustainability
Our Approach to Sustainability
Sustainable Innovation
Transfers of value to healthcare
Sustainable Business
Code of Conduct
Policies
Whistleblower
Investors
Back
Investors
Six reasons to invest in BioArctic
The share
Annual report 2023
Financial reports and presentations
Conference presentations
Shareholder information
Share capital development
Dividend
Ownership structure
Analysts
Privacy policy Shareholders
Press releases
Prospectus
Calendar
IR contacts
Subscribe
Search for:
Search
Loading...
The share
Governance
Back
Governance
Governance Structure
General Meeting
General Meetings
Nomination Committee
Nomination Committees
Board of Directors
Work of the Board of Directors
Board Committees
Executive Management Team
Research and Development Leadership Team
Remuneration
Internal Control
Audit
Articles of Association
Corporate Governance Reports
Career
Back
Career
Leadership
Culture and values
Collaboration principles
Testimonials
Job openings
Open applications
Media
Back
Media
Press releases
Image bank
Subscribe
Contact us
BioArctic websites
Sweden
Norway
Finland
Denmark transparancy reporting
Search
Search for:
Press
to
Search
Loading...
The share
IR contacts
BioArctic
Investors
IR contacts
For further information, please contact
E-mail:
ir@bioarctic.com
Phone: +46 8 695 6930
Investor contact
Oskar Bosson
VP, Head of IR & Communication
+46704107180
[email protected]
